ARTICLE
Volume 4,Issue 2
28 December 2023
Research Progress on Dexmedetomidine Regulating Autophagy in the Treatment of Acute Lung Injury
Guanrong Li ,
Min Li ,
Ying Wang ,
Huijie Ma ,
Boya Zhang ,
Jun Chen ,
Yingui Sun
Show Less
1
Department of Anesthesiology, Affiliated Hospital of Weifang Medical University, Weifang 261000, Shandong Province, China,
2
Department of Anesthesiology, Affiliated Hospital of Weifang Medical University, Weifang 261000, Shandong Province, China,
3
Department of Anesthesiology, Affiliated Hospital of Weifang Medical University, Weifang 261000, Shandong Province, China,
4
Department of Anesthesiology, Affiliated Hospital of Weifang Medical University, Weifang 261000, Shandong Province, China,
5
Department of Anesthesiology, Affiliated Hospital of Weifang Medical University, Weifang 261000, Shandong Province, China,
6
Department of Anesthesiology, Affiliated Hospital of Weifang Medical University, Weifang 261000, Shandong Province, China,
7
Department of Anesthesiology, Affiliated Hospital of Weifang Medical University, Weifang 261000, Shandong Province, China,
CR 2023 , 1(3), 7–11;
https://doi.org/10.26689/cr.v1i3.5746
© 2023 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract
Dexmedetomidine, extensively utilized as an intravenous anesthetic in anesthesia, intensive care units, and other related medical departments, exhibits significant anti-inflammatory effects while inducing sedation. Numerous studies have demonstrated its capability to regulate autophagy, thereby exerting potent anti-inflammatory effects and offering therapeutic benefits in the treatment of acute lung injury. This article comprehensively reviews the mechanisms underlying autophagy, the role of dexmedetomidine in autophagy regulation, and the protective effects it conders in the context of acute lung injury. By doing so, it contributes positively to the arsenal of strategies aimed at both preventing and treating acute lung injury.
References
Mokrá D, 2020, Acute Lung Injury – From Pathophysiology to Treatment. Physiol Res, 69(Suppl 3): S353–S366. https://doi.org/10.33549/physiolres.934602
Xue L, 2021, Current Status and Future Treatment Strategies for Acute Lung Injury. Shanghai Medical Journal, 44(8): 571–575.
Zhang Z, Chen Z, Liu R, et al., 2020, Bcl-2 Proteins Regulate Mitophagy in Lipopolysaccharide-Induced Acute Lung Injury via PINK1/Parkin Signaling Pathway. Oxid Med Cell Longev, 2020: 6579696. https://doi.org/10.1155/2020/6579696
Glick D, Barth S, Macleod KF, 2010, Autophagy: Cellular and Molecular Mechanisms. J Pathol, 221(1): 3–12. https://doi.org/10.1002/path.2697
Parzych KR, Klionsky DJ, 2014, An Overview of Autophagy: Morphology, Mechanism, and Regulation. Antioxid Redox Signal, 20(3): 460–473. https://doi.org/10.1089/ars.2013.5371
Alers S, Löffler AS, Wesselborg S, et al., 2012, Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks. Mol Cell Biol, 32(1): 2–11. https://doi.org/10.1128/MCB.06159-11
Hu Y, 2017, Research on the Molecular Regulatory Mechanisms of mTOR and Autophagy in LPS-Induced Acute Lung Injury, thesis, Zhejiang University.
Zhu C-H, Yu J, Wang B-Q, et al., 2020, Dexmedetomidine Reduces Ventilator-Induced Lung Injury via ERK1/2 Pathway Activation. Mol Med Rep, 22(6): 5378–5384. https://doi.org/10.3892/mmr.2020.11612
Share
Back to top
Bio-Byword Scientific Publishing Pty. Ltd.
We are committed to supporting the scientific community by publishing impactful research and fostering effective communication among scientists. We continuously seek ways to accelerate scientific progress while upholding transparency and open dialogue. Our goal is to make knowledge freely and barrier‑free accessible to all.
Contact us: info@bbwpublisher.com
Level 10, 50 Clarence Street Sydney, NSW 2000 Australia